
MedCAD received FDA 510(k) clearance to market its AccuStride lower leg tibia and fibula system. The custom-made planning and surgical guides will enable orthopedic surgeons to correct multiple related pathologies and osteotomies in a single procedure.
The company received 510(k) FDA clearance for its foot and ankle guides and planning system in March 2025. In November 2025 MedCAD received 510(k) FDA clearance for its fixation plates, part of its patient-specific 3D-printed solution available to surgeons as a complete foot and ankle (F&A) system.
The AccuStride System includes surgical guides, plates and anatomical models. Components are constructed of UV-curable acrylate polymers or titanium alloy materials and can be delivered in as few as five days after surgeon design approval. The system is intended for use in patients 12 years and older.
System guides provide tactile placement of specific surgical procedural steps derived from the patient imaging data and the surgeon approved plan. The titanium guides are compatible with FDA-cleared surgical cutting/drilling instruments, and the physician selects the appropriate instruments to interface with each type of surgical device. The system’s anatomical models provide visual representation of a specific patient’s anatomy derived from the patient imaging data and the surgeon approved plan.
Source: MedCAD
MedCAD received FDA 510(k) clearance to market its AccuStride lower leg tibia and fibula system. The custom-made planning and surgical guides will enable orthopedic surgeons to correct multiple related pathologies and osteotomies in a single procedure.
The company received 510(k) FDA clearance for its foot and ankle guides and planning...
MedCAD received FDA 510(k) clearance to market its AccuStride lower leg tibia and fibula system. The custom-made planning and surgical guides will enable orthopedic surgeons to correct multiple related pathologies and osteotomies in a single procedure.
The company received 510(k) FDA clearance for its foot and ankle guides and planning system in March 2025. In November 2025 MedCAD received 510(k) FDA clearance for its fixation plates, part of its patient-specific 3D-printed solution available to surgeons as a complete foot and ankle (F&A) system.
The AccuStride System includes surgical guides, plates and anatomical models. Components are constructed of UV-curable acrylate polymers or titanium alloy materials and can be delivered in as few as five days after surgeon design approval. The system is intended for use in patients 12 years and older.
System guides provide tactile placement of specific surgical procedural steps derived from the patient imaging data and the surgeon approved plan. The titanium guides are compatible with FDA-cleared surgical cutting/drilling instruments, and the physician selects the appropriate instruments to interface with each type of surgical device. The system’s anatomical models provide visual representation of a specific patient’s anatomy derived from the patient imaging data and the surgeon approved plan.
Source: MedCAD
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.





